Vitamin D3
Dietary SupplementSupplement of vitamin D3
NCT Number: NCT01519986
The purpose of this study is to evaluate the absorption of dietary supplement of vitamin D3 (cholecalciferol), through the variation of 25 (OH) D levels, as the fat content of the meal associated with the administration of the supplement.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Residents of the hospital clinics of Porto Alegre
Exclusion criteria
Supplement of vitamin D3
Placebo
Time frame: Change from baseline in serum 25(OH)D at 14 days
25(OH)D response to supplemental vitamin D3
Time frame: Change from baseline in Parathyroid hormone at 14 days
Parathyroid hormone response to supplemental vitamin D3
Federal University of Rio Grande do Sul
Other
The Effect of Fat on Vitamin D Absorption After a Single Oral Dose
Acronym: VITD_100484
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07631312
Anemia, Anemia, Hypochromic
Atlanta, Georgia, United States
View Trial DetailsNCT06700122
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT06654063
Avitaminosis, Deficiency Diseases
Cairo, Egypt
View Trial DetailsNCT07481240
Avitaminosis, Deficiency Diseases
Cork, Co. Cork, Ireland
View Trial Details